| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 07/13/2023 | Taysha Gene Therapies, Inc. | | Sale | Common Stock | 5.3k | $0.70 | $3.7k | | 07/12/2023 |
| 07/12/2023 | Taysha Gene Therapies, Inc. | | Sale | Common Stock | 80.5k | $0.71 | $57k | | 07/12/2023 |
| 03/06/2023 | Taysha Gene Therapies, Inc. | | Disposition | Employee Stock Option (right to buy) | 199.5k | $1.95 | $389k | | 03/06/2023 |
| 03/06/2023 | Taysha Gene Therapies, Inc. | | Other (acquisition) | Common Stock | 251.3k | $0.00 | $0 | | 03/06/2023 |
| 11/10/2022 | Taysha Gene Therapies, Inc. | | Grant | | 199.5k | $1.95 | $389k | | 11/10/2022 |
| 02/23/2022 | Taysha Gene Therapies, Inc. | | Grant | Employee Stock Option (right to buy) | 217.8k | $5.96 | $1.3M | | 02/23/2022 |
| 11/23/2021 | Taysha Gene Therapies, Inc. | | Purchase | Common Stock | 26k | $12.65 | $329k | | 11/23/2021 |
| 11/23/2021 | Taysha Gene Therapies, Inc. | | Purchase | Common Stock | 16.5k | $12.12 | $200.1k | | 11/23/2021 |
| 01/19/2021 | Taysha Gene Therapies, Inc. | | Grant | Stock Option (Right to Buy) | 199.7k | $31.00 | $6.2M | | 01/19/2021 |
| 03/13/2018 | AveXis, Inc. | AVXS | Grant | Employee Stock Option (Right to Buy) | 6.6k | $133.80 | $879.3k | | 03/13/2018 |
| 03/13/2018 | AveXis, Inc. | AVXS | Grant | Common Stock | 1.7k | $0.00 | $0 | | 03/13/2018 |